Clincosm LogoSign in Get a demo

A Multicenter Observational Cohort of Degenerative Spine Diseases in China（DSDC）

Sponsor
Xiamen University (Other)
Overall Status
Completed
CT.gov ID
NCT05867732
Collaborator
(none)
10,000
Enrollment
1
Location
12
Actual Duration (Months)
833.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Study type: The objectives of this observational study were to understand, analyze, and compare the treatment and prognosis of patients with degenerative spine diseases and to construct a risk warning model and an assisted decision-making system

The main questions it aims to answer are:

  • [question 1] to construct a database of patients with degenerative spinal diseases and to study their associated prognosis, complications, and other risks

  • [Question 2] Use big data to build a risk early warning model and assisted decision making system The study will not intervene with patients

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    10000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Other
    Official Title:
    A Multicenter Observational Cohort of Degenerative Spine Diseases in China
    Actual Study Start Date :
    Mar 1, 2022
    Actual Primary Completion Date :
    Mar 10, 2022
    Actual Study Completion Date :
    Mar 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Collect demographics (Hospital Information System) [2022.03]

      Collect demographics from the HIS system for patients with degenerative spine disease

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:

    • patients with degenerative spine disease admitted to the units participating in the study from January 2015 to mid-January 2022;

    • complete patient data with no more than 5% missing;

    Exclusion Criteria:
    • Patients with oncology;

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Wenle Li Xianmen China 361102

    Sponsors and Collaborators

    • Xiamen University

    Investigators

    • Principal Investigator: Wenle Wenle, M.D., Xiamen University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Wenle Li, Dr., Xiamen University
    ClinicalTrials.gov Identifier:
    NCT05867732
    Other Study ID Numbers:
    • XiamenUDSDC
    First Posted:
    May 22, 2023
    Last Update Posted:
    May 22, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Spinal Diseases

    Study Results

    No Results Posted as of May 22, 2023